Joven, Jorge

Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis

Cufí, S., Vazquez-Martin, A., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., & Menendez, J. A. (2010) · Cell Cycle

TGF-β signaling in diseasesCancer Cells and Metastasis

Cited by 216

Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation

Cuyàs, E., Verdura, S., Llorach-Parés, L., Fernández-Arroyo, S., Joven, J., Martin-Castillo, B., Bosch-Barrera, J., Brunet, J., Nonell-Canals, A., Sanchez-Martinez, M., et al. (2018) · Frontiers in Endocrinology

Sirtuins and Resveratrol in MedicineComputational Drug Discovery Methods

Cited by 122

Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy: A Randomized Trial

van Wijk, J. P. H., de Koning, E. J. P., Cabezas, M. C., op't Roodt, J., Joven, J., Rabelink, T. J., & Hoepelman, A. I. (2005) · Annals of Internal Medicine

HIV-related health complications and treatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3